NOVALIQ

Anti-infectives; veterinary pharmaceutical preparations for treatment of ophthalmic disease; pharmaceutical preparations for ophthalmic use; medicinal preparations and pharmaceutical substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for the treatment of ocular surface diseases; pharmaceutical preparations for use in dermatology; medicated preparations for skin treatment; antimicrobials for dermatologic use; anti-dermoinfectives; pharmaceutical preparations for dental use; pharmaceutical preparations for the treatment of posterior eye diseases; pharmaceutical preparations for topical use for treating dermatologic conditions; pharmaceutical water-free preparations (exclusive medicaments, medicines), namely aids in the nature of veterinary pharmaceutical preparations for topical treatment of eye diseases and disorders and active substances comprising semifluorinated alkanes (SFAs) being medical aids.

Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; scientific and technological consultancy relating to the syntheses and production of pharmaceuticals; clinical research in the fields of ophthalmic pharmaceutical preparations, dermatologic pharmaceutical preparations, semifluorinated alkanes (SFAs) and of topical medical treatments; testing, authentication and quality control for others in the field of semifluorinated alkanes (SFAs) and of water-free pharmaceutical preparations.